Fernanda Viviane Mariano Selected Research

Fernanda Viviane Mariano Research Topics

Disease

22	Neoplasms (Cancer) 03/2024 - 06/2015
10	Carcinoma (Carcinomatosis) 03/2024 - 07/2015
7	Pleomorphic Adenoma 03/2024 - 06/2015
5	Squamous Cell Carcinoma of Head and Neck 12/2022 - 09/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2023 - 12/2019
2	Head and Neck Neoplasms (Head and Neck Cancer) 03/2024 - 01/2024
2	Carcinogenesis 02/2024 - 10/2020
2	Adenocarcinoma 01/2018 - 12/2016
1	Atrophy 02/2024
1	Ameloblastoma 01/2024
1	Colorectal Neoplasms (Colorectal Cancer) 01/2024
1	Oral Leukoplakia 02/2023
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 03/2022
1	Oropharyngeal Neoplasms 12/2019
1	Neoplasm Metastasis (Metastasis) 05/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Ototoxicity 01/2018
1	Adenoma (Adenomas) 01/2018
1	Adenoid Cystic Carcinoma (Cylindroma) 12/2016
1	Acinar Cell Carcinoma 12/2016
1	Noninfiltrating Intraductal Carcinoma (DCIS) 07/2015
1	Giant Cell Tumors (Giant Cell Tumor) 11/2013
1	Mammary Analogue Secretory Carcinoma 10/2013
1	Margins of Excision 01/2013
1	Hemangioma (Angioma) 05/2011

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2023 - 06/2015
5	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 03/2017
4	MicroRNAs (MicroRNA)IBA 03/2024 - 10/2020
4	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 09/2016
3	Perilipin-2IBA 04/2022 - 10/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 03/2024 - 03/2019
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2024
2	CytokinesIBA 01/2024 - 01/2022
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 12/2021 - 03/2019
2	NucleotidesIBA 10/2020 - 07/2020
2	Caspase 3 (Caspase-3)IBA 07/2020 - 12/2019
2	CateninsIBA 05/2020 - 01/2018
2	Phenobarbital (Luminal)FDA Link 12/2016 - 07/2015
1	Estrogens (Estrogen)FDA Link 02/2024
1	EphrinsIBA 01/2024
1	SuspensionsIBA 01/2024
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2024
1	ParaffinIBA 01/2024
1	ChromograninsIBA 12/2023
1	SynaptophysinIBA 12/2023
1	Carboplatin (JM8)FDA LinkGeneric 11/2023
1	Docetaxel (Taxotere)FDA Link 11/2023
1	Fluorouracil (Carac)FDA LinkGeneric 11/2023
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 02/2023
1	Capsules (Microcapsules)IBA 01/2023
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 12/2022
1	Phosphotransferases (Kinase)IBA 12/2022
1	Tyrosine Kinase InhibitorsIBA 12/2022
1	DesminIBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	CAM 5.2 antigenIBA 01/2022
1	CalponinsIBA 01/2022
1	MART-1 AntigenIBA 01/2022
1	Extracellular Matrix ProteinsIBA 01/2022
1	ChemokinesIBA 01/2022
1	AntibodiesIBA 05/2019
1	Dynamins (Dynamin)IBA 05/2019
1	N 30IBA 01/2019
1	Deubiquitinating Enzyme CYLDIBA 01/2018
1	Muramidase (Lysozyme)IBA 12/2016
1	NexusIBA 11/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2015
1	LipidsIBA 10/2013
1	ethanolamine oleate (Ethamolin)FDA Link 05/2011

Therapy/Procedure

5	Radiotherapy 03/2024 - 01/2013
4	Therapeutics 11/2023 - 05/2020
2	Immunotherapy 01/2024 - 03/2022
1	Oral Pathology 01/2024
1	Chemoradiotherapy 11/2023
1	Induction Chemotherapy 11/2023
1	Aftercare (After-Treatment) 01/2018
1	Surgical Amputation (Amputations) 11/2013
1	Sclerotherapy 05/2011